obesity drug news today glp-1 october 23 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford How Supply and Demand for
Description
Semaglutide has consistently demonstrated strong weight reduction outcomes in clinical settings, making it a reference standard when evaluating GLP-1 performance metrics
Do I need to see a doctor in person first
Sometimes it is about recognising where the market is going and moving before everyone else
Many medications, particularly biologics, may not work as well in patients carrying extra weight
Despite these advances, several controversies remain unresolved
He told Stateline that funding drugs that can cut those costs down by even a small percentage is worth it over the long run
